|Bid||206.00 x 0|
|Ask||206.50 x 0|
|Day's range||206.00 - 209.00|
|52-week range||1.29 - 209.00|
|PE ratio (TTM)||6.02|
|Forward dividend & yield||0.02 (1.12%)|
|1y target est||N/A|
Syncona Limited LEI: 213800X8MBI5VQITLW60 Notification of Transactions by Persons Discharging Managerial Responsibilities ("PDMRs") and Connected Persons 18 January 2018 1. Details of PDMR / ...
Syncona Limited (a closed-ended investment company incorporated in Guernsey with registration number 55514) Monthly Fact Sheet October 2017 Attached is a link to the October 2017 Monthly Fact Sheet for ...
Syncona Limited (a closed-ended investment company incorporated in Guernsey with registration number 55514) Monthly Fact Sheet September 2017 Attached is a link to the September 2017 Monthly Fact Sheet ...
Syncona Ltd (“Syncona”), a leading healthcare company focused on investing in and building global leaders in life science, today notes that its portfolio company Nightstar Therapeutics plc (“Nightstar”) has today announced the closing of its previously announced initial public offering in the United States of 6,164,000 American Depositary Shares (“ADSs”) representing 6,164,000 ordinary shares, at an initial public offering price of $14.00, which includes an additional 804,000 ADSs issued upon the exercise in full by the underwriters of their option to purchase additional ADSs. All of the ADSs were offered by Nightstar.